Publications by authors named "Mark F Bird"

Claim this Profile
D
Differential opioid receptor expression and biochemical coupling profiles on glia.
Salim F Kadhim, John McDonald, Mark F Bird, Remo Guerrini, Girolamo Calo

Biochem Pharmacol· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cells.
Mark F Bird, Christopher P Hebbes, Anushuya Tamang, Jonathon Mark Willets, Jonathan P Thompson

Br J Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro sepsis induces Nociceptin/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cells.
Mark F Bird, Barbara Gallacher-Horley, John McDonald, David G McVey, Fatin Al-Janabi

PLoS One· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioids and cancer survival: are we looking in the wrong place?
Despina Giakomidi, Mark F Bird, David G Lambert

BJA Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescent opioid receptor ligands as tools to study opioid receptor function.
Despina Giakomidi, Mark F Bird, Remo Guerrini, Girolamo Calo, David G Lambert

J Pharmacol Toxicol Methods· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptors.
Despina Giakomidi, Mark F Bird, John McDonald, Erika Marzola, Remo Guerrini

PLoS One· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N/OFQ-NOP System in Peripheral and Central Immunomodulation.
Salim Kadhim, Mark F Bird, David G Lambert

Handb Exp Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403.
Federica Ferrari, Davide Malfacini, Blair V Journigan, Mark F Bird, Claudio Trapella

Pharmacol Res Perspect· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).
Mark F Bird, Maria Camilla Cerlesi, Mark Brown, Davide Malfacini, Vanessa Vezzi

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt]N/OFQ(1-13).
Maria Camilla Cerlesi, Huiping Ding, Mark F Bird, Norikazu Kiguchi, Federica Ferrari

Eur J Pharmacol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous targeting of multiple opioid receptor types.
Mark F Bird, David G Lambert

Curr Opin Support Palliat Care· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5.
Remo Guerrini, Erika Marzola, Claudio Trapella, Salvatore Pacifico, Maria Camilla Cerlesi, Mark Francis Bird

Bioorg Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis